Published on
17/06/2026 - 16:19 GMT+2
The EU health ministers on 16 June approved a common stance on a piece of legislation that accompanies the Biotech Act regulation — Biotech Act I directive.
The directive tweaks two directives on modified micro-organisms (GMMs) and the processing of organs. The aim — to make them more innovation-friendly, reduce administrative burdens and improve cross-border cooperation in organ transplantation, in a desperate attempt to catch up with biotech frontrunners — such as the US and China.
“Since the adoption of those directives significant progress in biotechnology has taken place,” Neophytos Charalambides, the Cyprus health minister, said. “Updating the respective legislations is therefore not only … a logical consequence, but also an ethical imperative,” he added.
